Search research articles
Contact Us
Filters
Showing results (21-30 of 126) with videos related to
Page
of 13
Sort By:
Genes, Chromosomes & Cancer
|
June 6, 2014
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns
Frederik Damm, Birgit Markus, Felicitas Thol, et al.
Biomaterials
|
June 10, 2017
An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries
Felix F Adams, Dirk Heckl, Thomas Hoffmann, et al.
Leukemia
|
June 17, 2018
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
Ioanna Triviai, Silke Zeschke, Jan Rentel, et al.
Haematologica
|
January 19, 2011
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype
Katharina Wagner, Frederik Damm, Felicitas Thol, et al.
Cancers
|
November 27, 2024
Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)
Martin Schönrock, Piet Sonnemann, Nina Michalowski, et al.
European Journal of Haematology
|
August 26, 2019
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation
Daniele Mannina, Nico Gagelmann, Anita Badbaran, et al.
Antimicrobial Resistance and Infection Control
|
June 21, 2022
Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients
Claas Baier, Jiabin Huang, Kerstin Reumann, et al.
Oncotarget
|
November 2, 2017
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy
Min Yang, Zengkai Pan, Kezhi Huang, et al.
British Journal of Haematology
|
May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia
Frederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Leukemia Research
|
October 9, 2017
Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype
Laura Hörster, Richard F Schlenk, Michael Stadler, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 126) with videos related to
Sort By:
Page
of 13
Genes, Chromosomes & Cancer
|
June 6, 2014
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns
Frederik Damm, Birgit Markus, Felicitas Thol, et al.
Biomaterials
|
June 10, 2017
An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries
Felix F Adams, Dirk Heckl, Thomas Hoffmann, et al.
Leukemia
|
June 17, 2018
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
Ioanna Triviai, Silke Zeschke, Jan Rentel, et al.
Haematologica
|
January 19, 2011
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype
Katharina Wagner, Frederik Damm, Felicitas Thol, et al.
Cancers
|
November 27, 2024
Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)
Martin Schönrock, Piet Sonnemann, Nina Michalowski, et al.
European Journal of Haematology
|
August 26, 2019
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation
Daniele Mannina, Nico Gagelmann, Anita Badbaran, et al.
Antimicrobial Resistance and Infection Control
|
June 21, 2022
Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients
Claas Baier, Jiabin Huang, Kerstin Reumann, et al.
Oncotarget
|
November 2, 2017
Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy
Min Yang, Zengkai Pan, Kezhi Huang, et al.
British Journal of Haematology
|
May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemia
Frederik Damm, Katharina Wagner, Kerstin Görlich, et al.
Leukemia Research
|
October 9, 2017
Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype
Laura Hörster, Richard F Schlenk, Michael Stadler, et al.
Page
of 13